Recursion Pharmaceuticals (RXRX) Asset Utilization Ratio (2021 - 2026)

Recursion Pharmaceuticals has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.05 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 8.71% year-over-year to 0.05; the trailing twelve-month figure through Mar 2026 stood at 0.05 (up 8.71% YoY), and the FY2025 full-year result was 0.05, down 8.7% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.05, down from 0.05 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.09 in Q3 2024, with the low at 0.02 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.06 across 5 years, with a median of 0.05 in 2024.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 278.38% — and 2025, when it plunged 62.73%.
• Recursion Pharmaceuticals' Asset Utilization Ratio stood at 0.06 in 2022, then grew by 14.34% to 0.07 in 2023, then slipped by 22.05% to 0.05 in 2024, then declined by 3.93% to 0.05 in 2025, then dropped by 9.18% to 0.05 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.05 (Q1 2026), 0.05 (Q4 2025), and 0.03 (Q3 2025), per Business Quant data.